SCHEMBL22922540

SCHEMBL22922540

C#CCN(c1ccc(NS(=O)(=O)c2c(C)cc(OC)cc2C)c2ccccc12)[C@@H](C)CC(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 17/20 0.42
▸ NFE2L2 Q16236 9/20 0.42
▸ SQSTM1 Q13501 1/20 0.37
▸ TP53 P04637 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ CASP1 P29466 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ MITF O75030 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ HKDC1 Q2TB90 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24299824 0.93 KEAP1 (0.45) KEAP1NFE2L2SQSTM1
SCHEMBL29539657 0.93 KEAP1 (0.45) KEAP1NFE2L2SQSTM1
SCHEMBL26357034 0.93 KEAP1 (0.47) KEAP1NFE2L2TP53MAPTALDH1A1
SCHEMBL26357069 0.90 KEAP1 (0.42) KEAP1NFE2L2TP53MAPTALDH1A1
SCHEMBL26357214 0.89 NMT1 (0.42) KEAP1NFE2L2TP53MAPTALDH1A1
SCHEMBL26356347 0.87 KEAP1 (0.57) KEAP1NFE2L2SQSTM1TP53MAPT
SCHEMBL26356959 0.86 KEAP1 (0.56) KEAP1NFE2L2SQSTM1TP53MAPT
SCHEMBL24299972 0.86 KEAP1 (0.39) KEAP1NFE2L2SQSTM1TP53MAPT
SCHEMBL26357187 0.85 KEAP1 (0.47) KEAP1NFE2L2SQSTM1MAPTALDH1A1
SCHEMBL22922454 0.85 KEAP1 (0.48) KEAP1NFE2L2SQSTM1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application CHINA PHARMACEUTICAL UNIVERSITY (CN) 2023-10-03 — — US disclosed
WO-2021012721-A1 NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION 中国药科大学 2021-01-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773057-B2 Naphthalenesulfonamide compound, preparation method, and application NFE2L2, KEAP1, NFE2 KEAP1 2/4885NFE2L2 1/4885SQSTM1 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback